drugset / Trial / NCT03234816
Vasopressor Prophylaxis After Spinal Anesthesia
RandomizedParallel-groupTriple-blindPrevention
Summary
Norepinephrine has been recently introduced as a prophylactic vasopressor during Cesarean delivery with promising results ; However, the optimum dose for efficient prophylaxis with the least side effects is not known. In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against Post-Spinal hypotension during cesarean delivery.
Timeline
- Start
- 2017-08-02
- Primary completion
- 2018-11-02
- Completion
- 2018-12-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norepinephrine | Other / unclassified | 0.05 ug/kg | — |
| Subject | Norepinephrine | Other / unclassified | 0.1 ug/kg | — |
| Subject | Norepinephrine | Other / unclassified | 0.15 ug/kg | — |
| Background | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |
Indications
No indication recorded.